The first company that comes up with a effective drug for obesity is bound to make billions.

Prior failures notwithstanding, a trio of small pharmaceutical companies are trying to come up with the next great obesity pill. That means clinical studies are ongoing.

So, what's it like to participate in such a trial? Ed Susman, a contributing writer at MedPage Today, was involved in one, ...

Read more...

Representatives from drug companies are undergoing some hard times, as physicians increasingly are closing their doors to them, or seeing them only via an appointment.

Subsequently, the number of drug reps is predicted to fall from about 102,000 at its peak in 2007, to 75,000 by 2012.

There are a variety of reasons for this, including the fact that more doctors simply don't trust the information that's presented, ...

Read more...

Beginning this year, inhaled beta-agonist asthma medications had to switch to a more environmentally friendly form.

MedPage Today has a special report on the issue, one where most primary care doctors were not well educated on.

Apparently, the new inhalers, which use hydrofluoroalkane (HFA) as a propellant, have been attracting a litany of patient complaints, including that the medicine tastes funny, the propellant isn't as strong, it's less ...

Read more...

You may have heard the story of anesthesiologist Scott Reuben, who allegedly fabricated the results of 21 medical studies.

Orac, over at his blog Respectful Insolence, provides some perspective of the issue, saying, "Dr. Reuben's fraud appears to eclipse even that of Andrew Wakefield [the disgraced researcher who wrongly linked autism to the MMR vaccine]."

Apparently, the pressure for academic physicians to generate results is intense, often with ...

Read more...

So, while watching Lost the other night, I saw an add for a local grocery chain advertising free antibiotics.

Apparently, it's a nationwide promotion, with multiple chains using antibiotics as a "loss leader" to bring people into their stores.

Well, it has now gotten the attention of both the CDC and the Infectious Diseases Society of America, with latter organization writing, "If you give antibiotics ...

Read more...

In the staid world of drug research, this is about as scandalous as it gets.

The antipsychotic drug quetiapine, or Seroquel, is coming under fire. As MedPage Today reports, damning e-mails from the past are resurfacing, implicating the drug maker for "burying" studies linking the drug to weight gain and diabetes.

But here's where it gets juicy.

AstraZeneca's former US medical director has admitted prior sexual ...

Read more...

Op-ed: Pads, pens, prescriptions

The following op-ed was published on February 26, 2009 in the USA Today. Have you ever noticed the pens, coffee mugs and prescription pads at your doctor's office? Chances are, they were prominently adorned with the brand name of the prescription drug its company is touting. The pharmaceutical industry has been giving these types of small gifts to doctors for years, in hopes of raising physician awareness of ...

Read more...

So, what's better than having one opinion piece published in a week?

Well, how about two.

My latest USA Today op-ed was published this morning: Pads, pens, prescriptions.

I talk about the "voluntary ban" that the pharmaceutical industry has instituted on itself, preventing doctors from receiving any type of gifts from drug representatives.

Will restricting gifts to doctors remove the specter of Big ...

Read more...

When looking for a prescription of Viagra, Cialis, or Levitra, make sure you get the real thing.

Amy Tuteur points to a recent NEJM article detailing cases in Singapore where hospitalized men were found to have taken imitation erectile dysfunction medications containing contaminents like the glucose-lowering medication glyburide, as well as host of herbal substances.

Glyburide, in particular, can be deadly in those who do not have diabetes, ...

Read more...

Fibromyalgia is a condition that has no clear cause, and there's no definitive diagnostic test.

However, there is no doubt that the symptoms are real, and many patients are suffering from the disease. Two brand-name medications, Lyrica and Cymbalta, represent several billion dollars in revenue.

The Washington Post points out that both Pfizer and Eli Lilly donated more than $6 million in education funding in 2008 to ...

Read more...

Most Popular

Join 141,000+ subscribers

Get the best of KevinMD in your inbox

Sign me up! It's free. 
close-link
✓ Join 141,000+ subscribers 
✓ Get KevinMD's 5 most popular stories
Subscribe. It's free.
close-image